|
Program 1: The Antipoverty Vaccines: R&D and clinical testing of a new generation of vaccines to combat the neglected tropical diseases (NTDs) |
|
 | Human Hookworm Vaccine Initiative
Learn More » |
|
Onchocerciasis (River Blindness) | Based on a significant investment from the Bill and Melinda Gates Foundation in laboratory infrastructure and units devoted to antigen discovery, bioprocess development, quality control, quality assurance, clinical trials, and regulatory affairs the Sabin Vaccine Institute is prepared to take on vaccine development projects for additional antipoverty vaccines. Accordingly, the Institute is urgently seeking funds for the development and testing of new vaccines for onchocerciasis (river blindness) and schistosomiasis (snail fever), leptospirosis, and other NTDs.
|
|
|
Program 2: Advocacy for Reducing the Global Burden of Infectious Diseases |
|
| GNNTDC - Global Network for Neglected Tropical Disease Control
GNNTDC is a partnership formed to raise the profile of neglected diseases and to stimulate a paradigm shift in neglected disease control efforts. For the first time, the neglected tropical disease community is coming together in a large-scale effort to integrate their parallel control programs in order to make a rapid-impact on the most prevalent neglected diseases among the world’s poorest populations – the 2.7 billion people living on less than US $2/day. Learn More » |
|
|
|
| Rotavirus Vaccine Advocacy
The Institute launched an advocacy initiative in 2003 to call attention to the burden of a disease with devastating health impact--rotavirus. Ciro de Quadros, MD, MPH, SVI President and CEO, a.i. says, "The search for a rotavirus vaccine is a high priority of both the World Health Organization and the Pan American Health Organization. The availability of such a vaccine will be a major contribution to the survival of children around the world." Learn More » |
|
Rubella Elimination
The Sabin Vaccine Institute partnered in 2005 with the Pan American Health Organization (PAHO) to conduct advocacy contributing to elimination of rubella and congenital rubella syndrome (CRS) in the Americas. An agreement signed in March 2005 defines a project that will focus on four countries: Guatemala, Nicaragua, Bolivia, and Paraguay. Learn More » |
|
Advocacy for Sustainable Immunization Financing The Sabin Vaccine Institute launched in 2007 a global advocacy effort to help
countries finance their national immunization systems. The aim of the Advocacy
Project is to help the countries increase the fiscal space for immunization by
attracting new sources of funding. Learn more »
|
|
Open Statement on Vaccines
Physicians and health experts are encouraged to sign an Open Letter emphasizing the critical role of vaccines in protecting public health. Concern over confusing media coverage, widespread Internet misinformation, and the risk of falling immunization rates prompted more than 100 of the nation's top physicians and public health experts to sign the Open Letter publicizing their strong, unwavering support for vaccines. Learn More » |
|
Annual Vaccine Policy Colloquium
The research and development of new or improved vaccines is challenging; but at times, no less daunting are the policy issues that arise in the process. A key goal has been to bring together prominent individuals from diverse areas of expertise who under normal circumstances have had insufficient opportunity to interact with each other despite sharing common areas of interest and concern. Each meeting has been organized around a major policy question with the hope that through free and open communication in an informal setting the process of problem solving could be accelerated. Learn More » |
|
|
Program 3: Vaccine Training and Education
|
|
| Building on a previously successful masters program in public health microbiology and emerging infections, established by Sabin Vaccine Institute President, Dr. Peter Hotez, plans are underway to establish a new M.S. Program in Vaccine Translational Research and Biotechnology jointly between GWU and the Sabin Vaccine Institute. The Sabin Vaccine Institute and GWU will also jointly sponsor postdoctoral fellows in this area. Another opportunity for training is to focus on capacity building in developing countries and the training of future vaccinologists overseas. |
|
